Thomas J. Connor - Publications

Affiliations: 
Trinity College, Dublin, Dublin, County Dublin, Ireland 
Website:
http://www.tcd.ie/Physiology/text/staff/connort.html

82 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Yssel JD, O'Neill E, Nolan YM, Connor TJ, Harkin A. Treatment with the noradrenaline re-uptake inhibitor atomoxetine alone and in combination with the α2-adrenoceptor antagonist idazoxan attenuates loss of dopamine and associated motor deficits in the LPS inflammatory rat model of Parkinson's disease. Brain, Behavior, and Immunity. PMID 29339319 DOI: 10.1016/j.bbi.2018.01.004  0.56
2017 O'Farrell K, Fagan E, Connor TJ, Harkin A. Inhibition of the kynurenine pathway protects against reactive microglial-associated reductions in the complexity of primary cortical neurons. European Journal of Pharmacology. PMID 28688912 DOI: 10.1016/j.ejphar.2017.07.008  0.56
2017 Abautret-Daly Á, Dempsey E, Riestra S, de Francisco-García R, Parra-Blanco A, Rodrigo L, Medina C, Connor TJ, Harkin A. Association between psychological measures with inflammatory anddisease-related markers of inflammatory bowel disease. International Journal of Psychiatry in Clinical Practice. 1-10. PMID 28353360 DOI: 10.1080/13651501.2017.1306081  0.56
2016 O'Neill E, Kwok B, Day JS, Connor TJ, Harkin A. Amitriptyline protects against TNF-α-induced atrophy and reduction in synaptic markers via a Trk-dependent mechanism. Pharmacology Research & Perspectives. 4: e00195. PMID 27069625 DOI: 10.1002/prp2.195  0.56
2016 Ryan KM, Griffin ÉW, Ryan KJ, Tanveer R, Vanattou-Saifoudine N, McNamee EN, Fallon E, Heffernan S, Harkin A, Connor TJ. Clenbuterol activates the central IL-1 system via the β2-adrenoceptor without provoking inflammatory response related behaviours in rats. Brain, Behavior, and Immunity. PMID 26928198 DOI: 10.1016/j.bbi.2016.02.023  1
2016 Hughes MM, Connor TJ, Harkin A. Stress-related immune markers in depression: implications for treatment. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26775294 DOI: 10.1093/ijnp/pyw001  0.56
2015 Doucet MV, O'Toole E, Connor T, Harkin A. Small-molecule inhibitors at the PSD-95/nNOS interface protect against glutamate-induced neuronal atrophy in primary cortical neurons. Neuroscience. 301: 421-38. PMID 26071957 DOI: 10.1016/j.neuroscience.2015.06.004  1
2014 Frodl T, Carballedo A, Frey EM, O'Keane V, Skokauskas N, Morris D, Gill M, Hughes MM, Harkin A, Connor T. Expression of glucocorticoid inducible genes is associated with reductions in cornu ammonis and dentate gyrus volumes in patients with major depressive disorder. Development and Psychopathology. 26: 1209-17. PMID 25422956 DOI: 10.1017/S0954579414000972  1
2014 Gigliucci V, Gormley S, Gibney S, Rouine J, Kerskens C, Connor TJ, Harkin A. Characterisation of the antidepressant properties of nitric oxide synthase inhibitors in the olfactory bulbectomised rat model of depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1349-61. PMID 24931298 DOI: 10.1016/j.euroneuro.2014.05.003  1
2014 Gibney SM, Fagan EM, Waldron AM, O'Byrne J, Connor TJ, Harkin A. Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 917-28. PMID 24472498 DOI: 10.1017/S1461145713001673  1
2014 Minogue AM, Jones RS, Kelly RJ, McDonald CL, Connor TJ, Lynch MA. Age-associated dysregulation of microglial activation is coupled with enhanced blood-brain barrier permeability and pathology in APP/PS1 mice. Neurobiology of Aging. 35: 1442-52. PMID 24439957 DOI: 10.1016/j.neurobiolaging.2013.12.026  1
2014 Day JS, O'Neill E, Cawley C, Aretz NK, Kilroy D, Gibney SM, Harkin A, Connor TJ. Noradrenaline acting on astrocytic β₂-adrenoceptors induces neurite outgrowth in primary cortical neurons. Neuropharmacology. 77: 234-48. PMID 24126345 DOI: 10.1016/j.neuropharm.2013.09.027  1
2014 Connor TJ, Harkin A. Inflammation in the Pathogenesis of Depression Neuroinflammation and Cns Disorders. 261-288. DOI: 10.1002/9781118406557.ch11  1
2013 Pertl MM, Hevey D, Boyle NT, Hughes MM, Collier S, O'Dwyer AM, Harkin A, Kennedy MJ, Connor TJ. C-reactive protein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy. Brain, Behavior, and Immunity. 34: 108-19. PMID 23928287 DOI: 10.1016/j.bbi.2013.07.177  1
2013 Ryan KJ, Griffin É, Yssel JD, Ryan KM, McNamee EN, Harkin A, Connor TJ. Stimulation of central β2-adrenoceptors suppresses NFκB activity in rat brain: a role for IκB. Neurochemistry International. 63: 368-78. PMID 23896303 DOI: 10.1016/j.neuint.2013.07.006  1
2013 Kelly RJ, Minogue AM, Lyons A, Jones RS, Browne TC, Costello DA, Denieffe S, O'Sullivan C, Connor TJ, Lynch MA. Glial Activation in AβPP/PS1 Mice is Associated with Infiltration of IFNγ-Producing Cells. Journal of Alzheimer's Disease : Jad. PMID 23780663 DOI: 10.3233/JAD-130539  1
2013 Downer EJ, Jones RS, McDonald CL, Greco E, Brennan S, Connor TJ, Robertson IH, Lynch MA. Identifying early inflammatory changes in monocyte-derived macrophages from a population with IQ-discrepant episodic memory. Plos One. 8: e63194. PMID 23671673 DOI: 10.1371/journal.pone.0063194  1
2013 Jones RS, Minogue AM, Connor TJ, Lynch MA. Amyloid-β-induced astrocytic phagocytosis is mediated by CD36, CD47 and RAGE. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 8: 301-11. PMID 23238794 DOI: 10.1007/s11481-012-9427-3  1
2013 Gibney SM, McGuinness B, Prendergast C, Harkin A, Connor TJ. Poly I:C-induced activation of the immune response is accompanied by depression and anxiety-like behaviours, kynurenine pathway activation and reduced BDNF expression. Brain, Behavior, and Immunity. 28: 170-81. PMID 23201589 DOI: 10.1016/j.bbi.2012.11.010  1
2013 McCarthy KF, Connor TJ, McCrory C. Cerebrospinal fluid levels of vascular endothelial growth factor correlate with reported pain and are reduced by spinal cord stimulation in patients with failed back surgery syndrome. Neuromodulation : Journal of the International Neuromodulation Society. 16: 519-22; discussion 5. PMID 23136965 DOI: 10.1111/j.1525-1403.2012.00527.x  1
2012 Browne CA, O'Brien FE, Connor TJ, Dinan TG, Cryan JF. Differential lipopolysaccharide-induced immune alterations in the hippocampus of two mouse strains: effects of stress. Neuroscience. 225: 237-48. PMID 22917616 DOI: 10.1016/j.neuroscience.2012.08.031  1
2012 Beumer W, Gibney SM, Drexhage RC, Pont-Lezica L, Doorduin J, Klein HC, Steiner J, Connor TJ, Harkin A, Versnel MA, Drexhage HA. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. Journal of Leukocyte Biology. 92: 959-75. PMID 22875882 DOI: 10.1189/jlb.0212100  1
2012 Frodl T, Carballedo A, Hughes MM, Saleh K, Fagan A, Skokauskas N, McLoughlin DM, Meaney J, O'Keane V, Connor TJ. Reduced expression of glucocorticoid-inducible genes GILZ and SGK-1: high IL-6 levels are associated with reduced hippocampal volumes in major depressive disorder. Translational Psychiatry. 2: e88. PMID 22832853 DOI: 10.1038/tp.2012.14  1
2012 Hughes MM, Carballedo A, McLoughlin DM, Amico F, Harkin A, Frodl T, Connor TJ. Tryptophan depletion in depressed patients occurs independent of kynurenine pathway activation. Brain, Behavior, and Immunity. 26: 979-87. PMID 22683764 DOI: 10.1016/j.bbi.2012.05.010  1
2012 Collins LM, Toulouse A, Connor TJ, Nolan YM. Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease. Neuropharmacology. 62: 2154-68. PMID 22361232 DOI: 10.1016/j.neuropharm.2012.01.028  1
2012 Kerr DM, Burke NN, Ford GK, Connor TJ, Harhen B, Egan LJ, Finn DP, Roche M. Pharmacological inhibition of endocannabinoid degradation modulates the expression of inflammatory mediators in the hypothalamus following an immunological stressor. Neuroscience. 204: 53-63. PMID 21952131 DOI: 10.1016/j.neuroscience.2011.09.032  1
2011 Ryan KJ, Griffin EW, Connor TJ. Complementary anti-inflammatory actions of the β₂-adrenoceptor agonist clenbuterol and the glucocorticoid dexamethasone in rat brain. Journal of Neuroimmunology. 232: 209-16. PMID 21035874 DOI: 10.1016/j.jneuroim.2010.10.001  1
2010 Boyle NT, Connor TJ. Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern? British Journal of Pharmacology. 161: 17-32. PMID 20718737 DOI: 10.1111/j.1476-5381.2010.00899.x  1
2010 Gleeson LC, Ryan KJ, Griffin EW, Connor TJ, Harkin A. The β2-adrenoceptor agonist clenbuterol elicits neuroprotective, anti-inflammatory and neurotrophic actions in the kainic acid model of excitotoxicity. Brain, Behavior, and Immunity. 24: 1354-61. PMID 20599496 DOI: 10.1016/j.bbi.2010.06.015  1
2010 McNamee EN, Griffin EW, Ryan KM, Ryan KJ, Heffernan S, Harkin A, Connor TJ. Noradrenaline acting at beta-adrenoceptors induces expression of IL-1beta and its negative regulators IL-1ra and IL-1RII, and drives an overall anti-inflammatory phenotype in rat cortex. Neuropharmacology. 59: 37-48. PMID 20361987 DOI: 10.1016/j.neuropharm.2010.03.014  1
2010 McNamee EN, Ryan KM, Griffin EW, González-Reyes RE, Ryan KJ, Harkin A, Connor TJ. Noradrenaline acting at central beta-adrenoceptors induces interleukin-10 and suppressor of cytokine signaling-3 expression in rat brain: implications for neurodegeneration. Brain, Behavior, and Immunity. 24: 660-71. PMID 20193756 DOI: 10.1016/j.bbi.2010.02.005  1
2010 Campbell SJ, Meier U, Mardiguian S, Jiang Y, Littleton ET, Bristow A, Relton J, Connor TJ, Anthony DC. Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in multiple sclerosis and EAE. Brain, Behavior, and Immunity. 24: 738-46. PMID 20138139 DOI: 10.1016/j.bbi.2010.01.011  1
2010 O'Sullivan JB, Ryan KM, Harkin A, Connor TJ. Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge. Journal of Neuroimmunology. 220: 34-42. PMID 20061033 DOI: 10.1016/j.jneuroim.2009.12.007  1
2010 McNamee EN, Ryan KM, Kilroy D, Connor TJ. Noradrenaline induces IL-1ra and IL-1 type II receptor expression in primary glial cells and protects against IL-1beta-induced neurotoxicity. European Journal of Pharmacology. 626: 219-28. PMID 19818755 DOI: 10.1016/j.ejphar.2009.09.054  1
2009 Curtin NM, Boyle NT, Mills KH, Connor TJ. Psychological stress suppresses innate IFN-gamma production via glucocorticoid receptor activation: reversal by the anxiolytic chlordiazepoxide. Brain, Behavior, and Immunity. 23: 535-47. PMID 19217938 DOI: 10.1016/j.bbi.2009.02.003  1
2009 Curtin NM, Mills KH, Connor TJ. Psychological stress increases expression of IL-10 and its homolog IL-19 via beta-adrenoceptor activation: reversal by the anxiolytic chlordiazepoxide. Brain, Behavior, and Immunity. 23: 371-9. PMID 19159673 DOI: 10.1016/j.bbi.2008.12.010  1
2009 O'Sullivan JB, Ryan KM, Curtin NM, Harkin A, Connor TJ. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 12: 687-99. PMID 19046481 DOI: 10.1017/S146114570800967X  1
2008 Connor TJ. Don't stress out your immune system - just relax. Brain, Behavior, and Immunity. 22: 1128-9. PMID 18708135 DOI: 10.1016/j.bbi.2008.07.009  1
2008 Connor TJ, Starr N, O'Sullivan JB, Harkin A. Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma? Neuroscience Letters. 441: 29-34. PMID 18584961 DOI: 10.1016/j.neulet.2008.06.007  1
2008 Johnson KA, Kelly SP, Robertson IH, Barry E, Mulligan A, Daly M, Lambert D, McDonnell C, Connor TJ, Hawi Z, Gill M, Bellgrove MA. Absence of the 7-repeat variant of the DRD4 VNTR is associated with drifting sustained attention in children with ADHD but not in controls. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 927-37. PMID 18361436 DOI: 10.1002/ajmg.b.30718  1
2007 Boyle NT, Connor TJ. MDMA ("Ecstasy") suppresses the innate IFN-gamma response in vivo: a critical role for the anti-inflammatory cytokine IL-10. European Journal of Pharmacology. 572: 228-38. PMID 17689526 DOI: 10.1016/j.ejphar.2007.07.020  1
2006 Horrigan LA, Kelly JP, Connor TJ. Immunomodulatory effects of caffeine: friend or foe? Pharmacology & Therapeutics. 111: 877-92. PMID 16540173 DOI: 10.1016/j.pharmthera.2006.02.002  1
2006 Diamond M, Kelly JP, Connor TJ. Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 481-90. PMID 16388933 DOI: 10.1016/j.euroneuro.2005.11.011  1
2005 Corcoran C, Connor TJ, O'Keane V, Garland MR. The effects of vagus nerve stimulation on pro- and anti-inflammatory cytokines in humans: a preliminary report. Neuroimmunomodulation. 12: 307-9. PMID 16166810 DOI: 10.1159/000087109  1
2005 Connor TJ, Brewer C, Kelly JP, Harkin A. Acute stress suppresses pro-inflammatory cytokines TNF-alpha and IL-1 beta independent of a catecholamine-driven increase in IL-10 production. Journal of Neuroimmunology. 159: 119-28. PMID 15652410 DOI: 10.1016/j.jneuroim.2004.10.016  1
2005 Connor TJ, Harkin A, Kelly JP. Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-alpha independent of a beta-adrenoceptor-mediated increase in interleukin-10. The Journal of Pharmacology and Experimental Therapeutics. 312: 134-43. PMID 15331655 DOI: 10.1124/jpet.104.073023  1
2004 Horrigan LA, Kelly JP, Connor TJ. Caffeine suppresses TNF-alpha production via activation of the cyclic AMP/protein kinase A pathway. International Immunopharmacology. 4: 1409-17. PMID 15313438 DOI: 10.1016/j.intimp.2004.06.005  1
2004 Harkin A, Connor TJ, Burns MP, Kelly JP. Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 274-81. PMID 15163436 DOI: 10.1016/j.euroneuro.2003.08.010  1
2004 Connor TJ. Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system. Immunology. 111: 357-67. PMID 15056370 DOI: 10.1111/j.0019-2805.2004.01847.x  1
2003 Harkin A, Hynes MJ, Masterson E, Kelly JP, O'Donnell JM, Connor TJ. A toxicokinetic study of nickel-induced immunosuppression in rats. Immunopharmacology and Immunotoxicology. 25: 655-70. PMID 14686805 DOI: 10.1081/IPH-120026448  1
2003 Harkin A, Shanahan E, Kelly JP, Connor TJ. Methylenendioxyamphetamine produces serotonin nerve terminal loss and diminished behavioural and neurochemical responses to the antidepressant fluoxetine. The European Journal of Neuroscience. 18: 1021-7. PMID 12925028 DOI: 10.1046/j.1460-9568.2003.02802.x  1
2003 Harkin A, Connor TJ, Walsh M, St John N, Kelly JP. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacology. 44: 616-23. PMID 12668047 DOI: 10.1016/S0028-3908(03)00030-3  1
2002 Connor TJ, O'Sullivan J, Nolan Y, Kelly JP. Inhibition of constitutive nitric oxide production increases the severity of lipopolysaccharide-induced sickness behaviour: a role for TNF-alpha. Neuroimmunomodulation. 10: 367-78. PMID 12907844 DOI: 10.1159/000071478  1
2002 Connor TJ, Kelly JP. Fenfluramine-induced immunosuppression: an in vivo analysis. European Journal of Pharmacology. 455: 175-85. PMID 12445584 DOI: 10.1016/S0014-2999(02)02588-8  1
2002 Harkin A, Connor TJ, O'Donnell JM, Kelly JP. Physiological and behavioral responses to stress: what does a rat find stressful? Lab Animal. 31: 42-50. PMID 11927961 DOI: 10.1038/5000150  1
2001 Connor TJ, Connelly DB, Kelly JP. Methylenedioxymethamphetamine (MDMA; 'Ecstasy') suppresses antigen specific IgG2a and IFN-gamma production. Immunology Letters. 78: 67-73. PMID 11672589 DOI: 10.1016/S0165-2478(01)00231-0  1
2001 Harkin A, Connor TJ, Mulrooney J, Kelly JP, Leonard BE. Prior exposure to methylenedioxyamphetamine (MDA) induces serotonergic loss and changes in spontaneous exploratory and amphetamine-induced behaviors in rats. Life Sciences. 68: 1367-82. PMID 11388689 DOI: 10.1016/S0024-3205(00)01039-0  1
2001 Connor TJ, Dennedy MC, Harkin A, Kelly JP. Methylenedioxymethamphetamine-induced suppression of interleukin-1beta and tumour necrosis factor-alpha is not mediated by serotonin. European Journal of Pharmacology. 418: 147-52. PMID 11334877 DOI: 10.1016/S0014-2999(01)00928-1  1
2000 Nolan Y, Connor TJ, Kelly JP, Leonard BE. Lipopolysaccharide administration produces time-dependent and region-specific alterations in tryptophan and tyrosine hydroxylase activities in rat brain. Journal of Neural Transmission (Vienna, Austria : 1996). 107: 1393-401. PMID 11458992 DOI: 10.1007/s007020070003  1
2000 Connor TJ, Kelly JP, McGee M, Leonard BE. Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1beta and TNF-alpha secretion following an in vivo lipopolysaccharide challenge. Life Sciences. 67: 1601-12. PMID 10983854 DOI: 10.1016/S0024-3205(00)00743-8  1
2000 Kelliher P, Connor TJ, Harkin A, Sanchez C, Kelly JP, Leonard BE. Varying responses to the rat forced-swim test under diurnal and nocturnal conditions. Physiology & Behavior. 69: 531-9. PMID 10913793 DOI: 10.1016/S0031-9384(00)00213-4  1
2000 Connor TJ, Kelliher P, Shen Y, Harkin A, Kelly JP, Leonard BE. Effect of subchronic antidepressant treatments on behavioral, neurochemical, and endocrine changes in the forced-swim test. Pharmacology, Biochemistry, and Behavior. 65: 591-7. PMID 10764911 DOI: 10.1016/S0091-3057(99)00192-6  1
2000 Connor TJ, Kelly JP, Leonard BE. An assessment of the acute effects of the serotonin releasers methylenedioxymethamphetamine, methylenedioxyamphetamine and fenfluramine on immunity in rats. Immunopharmacology. 46: 223-35. PMID 10741902 DOI: 10.1016/S0162-3109(99)00180-0  1
2000 Connor TJ, Harkin A, Kelly JP, Leonard BE. Olfactory bulbectomy provokes a suppression of interleukin-1beta and tumour necrosis factor-alpha production in response to an in vivo challenge with lipopolysaccharide: effect of chronic desipramine treatment. Neuroimmunomodulation. 7: 27-35. PMID 10601816  1
1999 Dredge K, Connor TJ, Kelly JP, Leonard BE. Differential effect of a single high dose of the tricyclic antidepressant imipramine on interleukin-1beta and tumor necrosis factor-alpha secretion following an in vivo lipopolysaccharide challenge in rats. International Journal of Immunopharmacology. 21: 663-73. PMID 12609461 DOI: 10.1016/S0192-0561(99)00042-9  1
1999 Shen Y, Connor TJ, Nolan Y, Kelly JP, Leonard BE. Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat. Life Sciences. 65: 1773-86. PMID 10576557 DOI: 10.1016/S0024-3205(99)00430-0  1
1999 Connor TJ, Kelliher P, Harkin A, Kelly JP, Leonard BE. Reboxetine attenuates forced swim test-induced behavioural and neurochemical alterations in the rat. European Journal of Pharmacology. 379: 125-33. PMID 10497898 DOI: 10.1016/S0014-2999(99)00492-6  1
1999 Connor TJ, Song C, Leonard BE, Anisman H, Merali Z. Stressor-induced alterations in serotonergic activity in an animal model of depression. Neuroreport. 10: 523-8. PMID 10208583  1
1999 Harkin A, Kelly JP, McNamara M, Connor TJ, Dredge K, Redmond A, Leonard BE. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression. European Journal of Pharmacology. 364: 123-32. PMID 9932714 DOI: 10.1016/S0014-2999(98)00838-3  1
1999 Connor TJ, McNamara MG, Kelly JP, Leonard BE. 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy) administration produces dose-dependent neurochemical, endocrine and immune changes in the rat Human Psychopharmacology. 14: 95-104. DOI: 10.1002/(SICI)1099-1077(199903)14:2<95::AID-HUP72>3.0.CO;2-7  1
1999 Connor TJ. Comparative effects of various antidepressant drugs and the immunosuppressant dexamethasone on the T-lymphocyte proliferative response in vitro Medical Science Research. 27: 773-774.  1
1999 Shen Y, Connor TJ, Kelly JP, Leonard BE. Effects of chronic dietary supplementation with ω3 and ω6 fatty acid rich oils on lipopolysaccharide-induced behavioural responses and interleukin-1β secretion in the rat Medical Science Research. 27: 291-294.  1
1998 Connor TJ, Song C, Leonard BE, Merali Z, Anisman H. An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. Neuroscience. 84: 923-33. PMID 9579794 DOI: 10.1016/S0306-4522(97)00533-2  1
1998 Connor TJ, McNamara MG, Finn D, Currid A, O'Malley M, Redmond AM, Kelly JP, Leonard BE. Acute 3,4-methylenedioxymethamphetamine(MDMA) administration produces a rapid and sustained suppression of immune function in the rat. Immunopharmacology. 38: 253-60. PMID 9506825 DOI: 10.1016/S0162-3109(97)00084-2  1
1998 Connor TJ, Leonard BE. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sciences. 62: 583-606. PMID 9472719 DOI: 10.1016/S0024-3205(97)00990-9  1
1998 Connor TJ, Kelly JP, Leonard BE. Forced swim test-induced endocrine and immune changes in the rat: effect of subacute desipramine treatment. Pharmacology, Biochemistry, and Behavior. 59: 171-7. PMID 9443552 DOI: 10.1016/S0091-3057(97)00316-X  1
1997 Connor TJ, Kelly JP, Leonard BE. Forced swim test-induced neurochemical endocrine, and immune changes in the rat. Pharmacology, Biochemistry, and Behavior. 58: 961-7. PMID 9408201 DOI: 10.1016/S0091-3057(97)00028-2  1
1997 Connor TJ, Kelly JP, Leonard BE. Effect of acute desipramine treatment on immunological parameters in the rat Medical Science Research. 25: 209-211.  1
1996 Mescall FM, Kane MT, Keyes WM, Quinlan LR, Hynes AC, Jordan FM, McGarvey C, Kelly JP, O'Donnell JM, Kelliher P, Cotton KD, Hollywood MA, Thornbury KD, McHale NG, Curran AK, ... ... Connor TJ, et al. Royal academy of medicine in ireland section of biomedical sciences - Proceedings of summer meeting held june 1995 Irish Journal of Medical Science. 165: 224-238. DOI: 10.1007/BF02940256  1
1958 JEROME EA, MOODY JA, CONNOR TJ, GREMLER W. Rate of responding as a function of intertrial interval. Journal of Comparative and Physiological Psychology. 51: 248-50. PMID 13525499  0.52
1958 JEROME EA, MOODY JA, CONNOR TJ, RYAN J. Intesity of illumination and the rate of responding in a multiple-door situation. Journal of Comparative and Physiological Psychology. 51: 47-9. PMID 13513845 DOI: 10.1037/h0039830  0.52
1957 JEROME EA, MOODY JA, CONNOR TJ, FERNANDEZ MB. Learning in a multiple-door situation under various drive states. Journal of Comparative and Physiological Psychology. 50: 588-91. PMID 13502503 DOI: 10.1037/h0040264  0.52
Show low-probability matches.